3382 Results

People

  1. Hudis
    Hudis
  2. Soslow
    Soslow
  3. Gonen
    Gonen
  4. Ladanyi
    Ladanyi
  5. Motzer
    Motzer
  6. Rusch
    Rusch
  7. Patil
    Patil
  8. Barakat
    Barakat
  9. Kris
    Kris
  10. Scher
    Scher

Groups

  1. Department of Medicine (1176)
  2. Surgery (803)
  3. GSK Faculty (796)
  4. Solid Tumor Oncology Division (659)
  5. Sloan Kettering Institute Faculty (606)
  6. Survivorship Research (542)
  7. Department of Pathology and Laboratory Medicine (408)
  8. Center for Hematologic Malignancies (395)
  9. Epidemiology and Biostatistics (369)
  10. Hematologic Malignancies, Division of (342)
  1. "2011"
Formats
  1. Journal Article (2141)
  2. Meeting Abstract (988)
  3. Book Section (224)
  4. Conference Paper (18)
  5. Book Whole (11)
Groups
  1. Department of Medicine (1176)
  2. Surgery (803)
  3. GSK Faculty (796)
  4. Solid Tumor Oncology Division (659)
  5. Sloan Kettering Institute Faculty (606)
  6. Survivorship Research (542)

More Groups

People
  1. Robert Soslow (64)
  2. Clifford Hudis (60)
  3. Mithat Gonen (54)
  4. Marc Ladanyi (52)
  5. Robert Motzer (52)
  6. Valerie Rusch (47)

More People

Years
  1. 2011 (3382)
Publications
  1. Journal of Clinical Oncology (319)
  2. Blood (147)
  3. Cancer Research (122)
  4. International Journal of Radiation Oncology, Biology, Physics (104)
  5. Modern Pathology (70)
  6. Laboratory Investigation (65)

More Publications

Publishers
  1. Elsevier Inc. (450)
  2. American Society of Clinical Oncology (327)
  3. Springer (231)
  4. American Association for Cancer Research (180)
  5. Nature Publishing Group (157)
  6. Wiley Blackwell (154)

More Publishers

Results (3382)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterization of novel potent and selective anaplastic lymphoma kinase (ALK) inhibitors
    Meeting Abstract

    Lovly, C. M.; de Stanchina, E.; Chen, H.; Liang, C.; Pao, W.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Clinical outcomes in patients age 40 or younger at diagnosis of synchronous metastatic colorectal cancer: A 20-year experience at Memorial Sloan-Kettering Cancer Center
    Meeting Abstract

    Lowery, M. A.; Gallagher, D. J.; Capanu, M.; Chou, J. F.; Kemeny, N. E.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Evaluation of response rate and disease control rate as potential predictors of overall survival in anthracycline-pretreated women receiving first-line chemotherapy for metastatic breast cancer (MBC)
    Meeting Abstract

    Liu, J.; Albain, K. S.; Chan, S.; Seidman, A. D.; Tai, D.; Wang, Y.; Zhao, L.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Forced vital capacity (FVC) as a reproducible measure of pulmonary function (PF) in chemotherapy-pretreated patients with malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Krug, L. M.; Arduino, J. M.; Sun, X.; Kindler, H. L.; Manegold, C.; Fennell, D.; Lubiniecki, G. M.; Baas, P.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II study of chemoradiation plus bevacizumab (BV) for locally/regionally advanced nasopharyngeal carcinoma (NPC): Preliminary clinical results of RTOG 0615
    Meeting Abstract

    Lee, N. Y.; Zhang, Q. E.; Garden, A. S.; Kim, J. J.; Pfister, D. G.; Mechalakos, J.; Hu, K.; Le, Q.; Glisson, B. S.; Chan, A. T. C.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Presence of frequent underlying RAS mutations in cutaneous squamous cell carcinomas and keratoacanthomas (cuSCC/KA) that develop in patients during vemurafenib therapy
    Meeting Abstract

    Lacouture, M. E.; Chapman, P. B.; Ribas, A.; Sosman, J. A.; McArthur, G. A.; Flaherty, K. T.; Kim, K. B.; Puzanov, I.; Nolop, K. B.; Joe, A. K.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II AIDS Malignancy Consortium trial of imatinib in AIDS-associated Kaposi's sarcoma (KS)
    Meeting Abstract

    Koon, H. B.; Honda, K.; Lee, J. Y.; Noy, A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • CPX-351 versus cytarabine (CYT) and daunorubicin (DNR) therapy in newly diagnosed AML patients age 60-75: Safety and efficacy in secondary AML (sAML)
    Meeting Abstract

    Lancet, J. E.; Cortes, J. E.; Kovacsovics, T.; Hogge, D.; Kolitz, J. E.; Tallman, M. S.; Chiarella, M.; Louie, A. C.; Feldman, E. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Randomized, double-blinded, phase II trial of a WT1 peptide vaccine as adjuvant therapy in patients with malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Krug, L. M.; Tsao, A. S.; Kass, S.; Rusch, V. W.; Travis, W. D.; Panageas, K.; Adusumili, P. S.; Kris, M. G.; Maslak, P. G.; Scheinberg, D. A.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Postoperative adjuvant chemotherapy (CTX) use in patients (Pts) with stage II/III rectal cancer treated with neoadjuvant therapy: A National Comprehensive Cancer Network (NCCN) analysis
    Meeting Abstract

    Khrizman, P.; Niland, J. C.; ter Veer, A.; Milne, D.; Dunn, K. B.; Carson, W. E.; Engstrom, P. F.; Shibata, S.; Skibber, J. M.; Weiser, M. R.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save